Creative Biolabs provides a comprehensive analytical suite to quantify cellular turnover, identifying the transformation from normal cells to malignant phenotypes. By integrating high-throughput digital pathology and multi-omics, we pinpoint exactly where carcinogenic factors disrupt the cell cycle. Our deep learning models accurately differentiate between reactive hyperplasia and true neoplastic proliferation, translating complex dynamics into actionable data for predicting survival and monitoring therapy. This precision enables high-stakes decision-making in toxicology and drug efficacy studies, moving research from observation to definitive quantification.

Introduction of Proliferation Index Profiling Service

Cellular proliferation is the primary engine of cancer progression and a vital metric in assessing carcinogenic potential. Recent scientific literature highlights that while Ki67 remains the classic immunohistochemical marker, its evaluation suffers from high inter-observer variability when assessed manually. Advanced studies now emphasize the functional role of proliferating cell nuclear antigen (PCNA) phosphorylation (Y211) as a critical growth regulator and marker of DNA damage response, as well as the emerging power of deep learning radiomics to predict proliferation status non-invasively. Collectively, these findings underscore that a multi-dimensional approach—integrating molecular, functional, and imaging data—is essential for accurate carcinogenic risk assessment.

Quadruple-Layer Marker Strategy

Creative Biolabs captures the full landscape of tumor proliferation across four distinct layers:

Explore Our Scientific Expertise - Request a Technical Brief

Analytical Workflow

To ensure the highest data integrity, our workflow is standardized yet flexible enough to accommodate unique research goals and diverse sample types.

Publication

This study investigates a tri-marker proliferation index to predict biochemical recurrence in prostate cancer after radical prostatectomy. Using immunohistochemistry for Ki-67, TOP2A, and E2F1, the authors found that a combined index outperformed individual markers and enhanced prognostication beyond standard clinicopathological factors. The results support the utility of this proliferation signature for improved risk stratification and treatment decisions.

Fig.1 Proliferation signature cluster in prostate cancer. ¹

Why Choose Us?

Creative Biolabs leads the intersection of classical pathology and artificial intelligence through a unique "Quadruple-Layer" approach, capturing proliferation dynamics across protein, transcriptomic, functional signaling (pY211), and macro-radiological levels. By implementing deep learning radiomics, we achieve an AUC of 0.90+ in predicting proliferation status non-invasively, a breakthrough for longitudinal studies where repeated biopsies are impossible. Our platform maps spatial "hot spots" and "cold spots" with high resolution, providing a granular understanding of tumor heterogeneity. This methodology prioritizes reproducibility and clinical relevance, utilizing rigorous quality control to transform complex biological data into actionable intelligence for drug development and regulatory compliance.

Empower your research with functional and molecular precision. Contact our specialist team today to discuss how our AI-enhanced proliferation profiling can provide the definitive evidence your project requires.

FAQs

Customer Review

• Unmatched Spatial Precision
  Using Creative Biolabs' technology in our breast cancer research has facilitated our understanding of how the tumor microenvironment modulates Ki67 expression. The digital exclusion of stromal cells saved us months of manual counting and eliminated the variance seen in manual scoring. – Dr. Sarah W***
• Functional Insights into PCNA
  The pY211 phosphorylation assay provided the definitive evidence we needed to explain drug resistance in our c-Abl inhibitor study. The correlation between signaling activity and tumor growth was clear and provided a new angle for our mechanism of action papers. – Prof. Michael R***

Related Services

How to Contact Creative Biolabs

Creative Biolabs is dedicated to providing the most advanced, AI-integrated proliferation profiling available today. From non-invasive imaging to deep functional signaling, we provide the definitive evidence you need to move your project forward with confidence.

For detailed project discussions or to receive a custom quote tailored to your specific research needs, please reach out to our scientific team.

Reference

1. Malhotra, Sameer, et al. "A tri-marker proliferation index predicts biochemical recurrence after surgery for prostate cancer." PLoS One 6.5 (2011): e20293. Distributed under Open Access license CC BY 4.0, without modification. https://doi.org/10.1371/journal.pone.0020293

For Research Use Only | Not For Clinical Use